At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
thiapalmitate tracer +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
In Brief
A clinical study evaluating thiapalmitate tracer, Saline, and 1 other intervention for Type 2 Diabetes Mellitus. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Studies of myocardial fuel selection using a novel palmitate-based PET probe
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesUnited States
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2007
Primary CompletionJun 2009
First PostedSep 2015
TodayJul 2026
First PostedSep 30, 2015
Enrollment StartJan 1, 2007
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.8 years ago
Interventions
thiapalmitate tracerdrug
Radiolabeled tracer infusion; occurs in all treatment arms
Salinedrug
Saline infusion for control
Insulindrug
Insulin infusion for insulin/glucose clamp procedure